Related references
Note: Only part of the references are listed.When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease
Evangelina Avila-Munoz et al.
AGEING RESEARCH REVIEWS (2014)
Inflammation in neurodegenerative diseases-an update
Sandra Amor et al.
IMMUNOLOGY (2014)
Age-Dependent, Non-Cell-Autonomous Deposition of Amyloid from Synthesis of β-Amyloid by Cells Other Than Excitatory Neurons
Karthikeyan Veeraraghavalu et al.
JOURNAL OF NEUROSCIENCE (2014)
Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
Willem Kamphuis et al.
NEUROBIOLOGY OF AGING (2014)
Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory
Agostino Palmeri et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia
Mian Zhou et al.
BRAIN RESEARCH (2013)
Immunotherapy for Targeting Tau Pathology in Alzheimer's Disease and Tauopathies
Hanna Rosenmann
CURRENT ALZHEIMER RESEARCH (2013)
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice
Andrew W. Kraft et al.
FASEB JOURNAL (2013)
F3/Contactin Promotes Hippocampal Neurogenesis, Synaptic Plasticity, and Memory in Adult Mice
Daniela Puzzo et al.
HIPPOCAMPUS (2013)
Genetic insights in Alzheimer's disease
Karolien Bettens et al.
LANCET NEUROLOGY (2013)
Neuroinflammatory Cytokine Signaling and Alzheimer's Disease
W. Sue T. Griffin
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases
Michael Wong
Biomedical Journal (2013)
Mild cognitive impairment: Hope for stability, plan for progression
Birju B. Patel et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2012)
Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory
Daniela Puzzo et al.
NEUROBIOLOGY OF AGING (2012)
The role of inflammatory processes in Alzheimer’s disease
G. Joseph Broussard et al.
INFLAMMOPHARMACOLOGY (2012)
Target of Rapamycin (TOR) in Nutrient Signaling and Growth Control
Robbie Loewith et al.
GENETICS (2011)
When Is the Hippocampus Involved in Recognition Memory?
Gareth R. I. Barker et al.
JOURNAL OF NEUROSCIENCE (2011)
Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier
William A. Banks
IMMUNOTHERAPY (2010)
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Object recognition memory and the rodent hippocampus
Nicola J. Broadbent et al.
LEARNING & MEMORY (2010)
Oxidative stress in Alzheimer disease: A possibility for prevention
David J. Bonda et al.
NEUROPHARMACOLOGY (2010)
Neutralization of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Reduces Spinal Cord Injury Damage in Mice
Giuseppina Cantarella et al.
NEUROPSYCHOPHARMACOLOGY (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Multiple Roles of the Innate Immune System in the Regulation of Apoptosis and Inflammation in the Brain
Mark R. Griffiths et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
TNF-related apoptosis-inducing ligand level in Alzheimer's disease
Sermin Genc et al.
NEUROLOGICAL SCIENCES (2009)
Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice
Ann C. Mckee et al.
BRAIN RESEARCH (2008)
Interleukin-1 beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice
Bettina H. Clausen et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
Solomon S. Shaftel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Trail interacts redundantly with nitric oxide in rat astrocytes: Potential contribution to neurodegenerative processes
Giuseppina Cantarella et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Immunology and immunotherapy of Alzheimer's disease
HL Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2006)
TRAIL is expressed in the brain cells of Alzheimer's disease patients
D Uberti et al.
NEUROREPORT (2004)
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease
MR Hynd et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
A Almasan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains
RG Nagele et al.
BRAIN RESEARCH (2003)
Apo2L/TRAIL and its death and decoy receptors
HN LeBlanc et al.
CELL DEATH AND DIFFERENTIATION (2003)
Neutralization of TRAIL death pathway protects human neurional cell line from beta-amyloid toxicity
G Cantarella et al.
CELL DEATH AND DIFFERENTIATION (2003)
Inflammation in neurodegenerative disease - A double-edged sword
T Wyss-Coray et al.
NEURON (2002)
Activated microglia (BV-2) facilitation of TNF-α-mediated motor neuron death in vitro
BP He et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition
LB Willard et al.
EXPERIMENTAL BRAIN RESEARCH (2000)
Share Paper
